tm logo

Monitor this mark

View On USPTO

FETZIMA
Live/Registered
REGISTERED AND RENEWED

on 01 Jun 2024

Last Applicant/ Owned by

ALLERGAN SALES, LLC

1 N. WAUKEGAN ROAD

NORTH CHICAGO

IL

60064

Serial Number

85959226 filed on 13th Jun 2013

Registration Number

4519242 registered on 22nd Apr 2014

in the Principal Register

Correspondent Address

Matthew O. Brady

Matthew O. Brady AbbVie Inc.

AND-250C

IRVINE, CA 92612

United States

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

FETZIMA

Pharmaceutical preparations, namely, antidepressants

Classification Information

Class [005]
Pharmaceutical Products

Pharmaceutical preparations, namely, antidepressants

First Use Date in General

02th Dec 2013

First Use Date in Commerce

02th Dec 2013

Mark Details

Serial Number

No 85959226

Mark Type

No Service/Collective Mark

Attorney Docket Number

No ABVT116346

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Design Code(s)

01.05.25 -

Other representations of the sun

02.01.33 -

Grotesque men formed by letters, numbers, punctuation or geometric shapes

26.05.15 -

Four or more triangles

26.05.21 -

Triangles that are completely or partially shaded

Legal History

Show more

Status DateAction Taken
01st Jun 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
01st Jun 2024REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
01st Jun 2024REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
01st Jun 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
23rd Feb 2024TEAS SECTION 8 & 9 RECEIVED
19th Oct 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
19th Oct 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
19th Oct 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
22nd Apr 2023COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
25th May 2020NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED